NCT02290886View on ClinicalTrials.gov

A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 2, 2022

Study Completion Date

March 2, 2022

Conditions

Amyotrophic Lateral Sclerosis

Interventions

OTHER

Intravenous administration of placebo

DRUG

Intravenous administration of 1 million of MSC

DRUG

Intravenous administration of 2 million of MSC

DRUG

Intravenous administration of 4 million of MSC

Trial Locations (4)

14004

Hospital Regional Universitario Reina Sofía, Córdoba

29010

Hospital Regional Universitario de Málaga, Málaga

41009

Hospital Universitario Virgen Macarena, Servicio de Neurología, Seville

41013

Hospital Universitario Virgen del Rocío, Seville

All Listed Sponsors

collaborator

Iniciativa Andaluza en Terapias Avanzadas

OTHER

lead

Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

OTHER

NCT02290886 - A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral | Biotech Hunter | Biotech Hunter